PRESS RELEASE published on 12/20/2024 at 08:00, 1 year 8 months ago EMS : MISE EN OEUVRE DU REGROUPEMENT D'ACTIONS EMS annonce le regroupement d'actions pour rationaliser leur nombre et limiter la volatilité des cours. Effet au 31/12/2024. Impact sur les titres et échange automatique pour les actionnaires Euronext Titres EMS Regroupement D'actions Volatilité
BRIEF published on 10/17/2024 at 18:05, 1 year 10 months ago EMS : Croissance du Chiffre d'Affaires au 3ème Trimestre 2024 Chiffre D'affaires Innovation Imagerie Médicale EMS Onyx
BRIEF published on 10/17/2024 at 18:05, 1 year 10 months ago EMS: Revenue Growth in the 3rd Quarter of 2024 Innovation Medical Imaging Turnover EMS Onyx
PRESS RELEASE published on 10/17/2024 at 18:00, 1 year 10 months ago CHIFFRE D'AFFAIRES DU 3ÈME TRIMESTRE 2024 : EMS POURSUIT SA CROISSANCE EMS publie un chiffre d'affaires de 10 M€ au 3ème trimestre 2024, en hausse de 12% par rapport à 2023, avec croissance dans la radiologie et ostéodensitométrie Chiffre D'affaires Croissance EMS Radiologie Ostéodensitométrie
BRIEF published on 10/07/2024 at 18:05, 1 year 11 months ago EMS: Stable growth despite a tumultuous year Innovation Cybersecurity Growth Turnover Radiology
BRIEF published on 10/07/2024 at 18:05, 1 year 11 months ago EMS : Croissance stable malgré une année tumultueuse Chiffre D'affaires Croissance Innovation Cybersécurité Radiologie
PRESS RELEASE published on 10/07/2024 at 18:00, 1 year 11 months ago EMS : CROISSANCE ET INNOVATION AU 1ER SEMESTRE 2024 EMS (European Medical Solutions) publie un Chiffre d'affaires de 21,9 M€ au 1er semestre 2024, en hausse de 4%. Détails des résultats financiers et des perspectives de croissance Chiffre D'affaires Résultats Financiers Croissance Innovation EMS
BRIEF published on 07/18/2024 at 17:50, 2 years 1 month ago EUROPEAN MEDICAL SOLUTIONS: Turnover for the first half of 2024 Growth Turnover Radiology Osteodensitometry Products
BRIEF published on 07/18/2024 at 17:50, 2 years 1 month ago EUROPEAN MEDICAL SOLUTIONS : Chiffre d'affaires du 1er semestre 2024 Chiffre D'affaires Croissance Radiologie Ostéodensitométrie Produits
PRESS RELEASE published on 07/18/2024 at 17:45, 2 years 1 month ago EUROPEAN MEDICAL SOLUTIONS ( ex DMS Imaging) : Chiffre d'affaires du 1er semestre 2024. European Medical Solutions annonce une croissance de 4% de son chiffre d'affaires au 1er semestre 2024, avec dynamique commerciale et perspectives de croissance positive Chiffre D'affaires Croissance Radiologie Ostéodensitométrie European Medical Solutions
Published on 09/12/2026 at 02:35, 11 hours 31 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 15 hours 6 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 16 hours 1 minute ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 41 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 21 hours 6 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 36 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 51 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 56 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 22 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 51 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 7 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 7 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
